These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 24048376)
1. Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Hughes K; Flynn T; de Zoysa J; Dalbeth N; Merriman TR Kidney Int; 2014 Feb; 85(2):344-51. PubMed ID: 24048376 [TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women. Liu J; Zhang H; Dong Z; Zhou J; Ma Y; Li Y; Qian Q; Yuan Z; Zhang J; Yang Y; Wang X; Chen X; Zou H; Jin L; Wang J Int Urol Nephrol; 2017 Nov; 49(11):2035-2042. PubMed ID: 28856502 [TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Rasheed H; Hughes K; Flynn TJ; Merriman TR Circ Cardiovasc Genet; 2014 Dec; 7(6):830-7. PubMed ID: 25249548 [TBL] [Abstract][Full Text] [Related]
4. Time to target uric acid to retard CKD progression. Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448 [TBL] [Abstract][Full Text] [Related]
5. Influence of urate-lowering therapies on renal handling of uric acid. Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449 [TBL] [Abstract][Full Text] [Related]
6. Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. Hosoya T; Ohno I; Nomura S; Hisatome I; Uchida S; Fujimori S; Yamamoto T; Hara S Clin Exp Nephrol; 2014 Dec; 18(6):876-84. PubMed ID: 24448692 [TBL] [Abstract][Full Text] [Related]
7. No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study. Xiong A; Yao Q; He J; Fu W; Yu J; Zhang Z Osteoporos Int; 2016 Mar; 27(3):1031-1039. PubMed ID: 26588908 [TBL] [Abstract][Full Text] [Related]
8. Genetically Elevated Serum Uric Acid and Renal Function in an Apparently Healthy Population. Ge JY; Ji Y; Zhu ZY; Li X Urol Int; 2020; 104(3-4):277-282. PubMed ID: 31711059 [TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density. Dalbeth N; Topless R; Flynn T; Cadzow M; Bolland MJ; Merriman TR J Bone Miner Res; 2015 Jun; 30(6):985-91. PubMed ID: 25502344 [TBL] [Abstract][Full Text] [Related]
10. Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition. Lin H; Tu C; Niu Y; Li F; Yuan L; Li N; Xu A; Gao L; Li L Eur J Pharmacol; 2019 Jun; 853():371-380. PubMed ID: 31009635 [TBL] [Abstract][Full Text] [Related]
11. Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials. Efstathiadou A; Gill D; McGrane F; Quinn T; Dawson J J Am Heart Assoc; 2019 Sep; 8(17):e012738. PubMed ID: 31438759 [TBL] [Abstract][Full Text] [Related]
12. Aortic Stenosis and Renal Function: A Bidirectional Mendelian Randomization Analysis. Ciofani JL; Han D; Allahwala UK; Bhindi R J Am Heart Assoc; 2024 May; 13(9):e034102. PubMed ID: 38639330 [TBL] [Abstract][Full Text] [Related]
13. GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study. Ueda M; Fukui K; Kamatani N; Kamitsuji S; Matsuo A; Sasase T; Nishiu J; Matsushita M J Hum Genet; 2023 Oct; 68(10):699-704. PubMed ID: 37308567 [TBL] [Abstract][Full Text] [Related]
14. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice. Chen G; Tan ML; Li KK; Leung PC; Ko CH J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851 [TBL] [Abstract][Full Text] [Related]
15. Effects of Allopurinol on the Progression of Chronic Kidney Disease. Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; de Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; N Engl J Med; 2020 Jun; 382(26):2504-2513. PubMed ID: 32579811 [TBL] [Abstract][Full Text] [Related]
16. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice. Wang CP; Wang X; Zhang X; Shi YW; Liu L; Kong LD J Pharm Pharm Sci; 2010; 13(3):411-27. PubMed ID: 21092713 [TBL] [Abstract][Full Text] [Related]
17. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Terkeltaub R; Bushinsky DA; Becker MA Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043 [TBL] [Abstract][Full Text] [Related]
18. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function. Bove M; Cicero AFG; Borghi C Curr Hypertens Rep; 2017 Oct; 19(12):95. PubMed ID: 29071435 [TBL] [Abstract][Full Text] [Related]
19. Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study. Greenberg KI; McAdams-DeMarco MA; Köttgen A; Appel LJ; Coresh J; Grams ME Clin J Am Soc Nephrol; 2015 May; 10(5):776-83. PubMed ID: 25717072 [TBL] [Abstract][Full Text] [Related]
20. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]